Info & imagens

IMMUNOPHENOTYPIC CORRELATES AND OUTCOMES TO FIRST-LINE PEMBROLIZUMAB AMONG PATIENTS AGED 80 YEARS OR OLDER WITH PD-L1-HIGH (≥50%) NON-SMALL CELL LUNG CANCER

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Authors

Wang, Xinan

About the Journal

Journal: Brazilian Journal of Oncology

DOI: 10.1055/s-00059887

e-issn: 2526-8732

Publisher: Thieme Revinter Publicações Ltda.

Publisher address: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Conference

XXIII Congresso Brasileiro de Oncologia Clínica

Local: Windsor Convention & Expo Center

Data: November 3, 2022